World's Best Scientists 2026 revealed!
Lars Lannfelt

Lars Lannfelt

D-Index & Metrics

Medicine

D-Index
120
Citations
74693
World Ranking
3675
National Ranking
73

Overview

Lars Lannfelt is a researcher affiliated with Uppsala University in Sweden, specializing primarily in the field of Medicine. Their work spans several interrelated subfields including Physiology, Molecular Biology, Neurology, Cellular and Molecular Neuroscience, and Pharmacology. The main topics addressed in their research include Alzheimer's disease research and treatments, Nuclear Receptors and Signaling, Cholinesterase and Neurodegenerative Diseases, Prion Diseases and Protein Misfolding, Computational Drug Discovery Methods, Parkinson's Disease Mechanisms and Treatments, and Dementia and Cognitive Impairment Research.

Their scholarly output includes publications in several frequent and recognized scientific venues. These include:

  • Molecular and Cellular Neuroscience
  • Alzheimer's Research & Therapy
  • The Journal of Prevention of Alzheimer's Disease
  • Acta Neuropathologica Communications
  • Alzheimer's & Dementia

Among recent papers to which they have contributed are:

  • "The Amyloid-β Pathway in Alzheimer's Disease" published in 2021 in Molecular Psychiatry
  • "A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody" published in 2021 in Alzheimer's Research & Therapy
  • "Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease" published in 2022 in Neurotherapeutics
  • "Fluorine-18-Labeled Antibody Ligands for PET Imaging of Amyloid-β in Brain" published in 2020 in ACS Chemical Neuroscience
  • "ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease" published in 2021 in Neurobiology of Disease

Frequent collaborators contributing to their research efforts include Linda Söderberg, Christer Möller, Malin Johannesson, Martin Ingelsson, and Kaj Blennow.

Best Publications

  • Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

    Jean-Charles Lambert;Jean-Charles Lambert;Jean-Charles Lambert;Carla A Ibrahim-Verbaas;Denise Harold;Adam C Naj

  • Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

    M. Hutton;C. L. Lendon;P. Rizzu;M. Baker

  • Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

    D. Scheuner;C. Eckman;C. Eckman;M. Jensen;X. Song

  • Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

    E. I. Rogaev;R. Sherrington;E. A. Rogaeva;G. Levesque

  • A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease

    M Nikpay;A Goel;Won H-H.;L M Hall

  • A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid.

    Mike Mullan;Fiona Crawford;Karin Axelman;Henry Houlden

  • The Amyloid-β Pathway in Alzheimer's Disease.

    Harald Hampel;John Hardy;Kaj Blennow;Kaj Blennow;Christopher Chen

  • The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.

    Camilla Nilsberth;Anita Westlind-Danielsson;Anita Westlind-Danielsson;Christopher B. Eckman;Margaret M. Condron

  • Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.

    Valentina Escott-Price;Céline Bellenguez;Li-San Wang;Seung-Hoan Choi

  • The genetic architecture of type 2 diabetes

    Christian Fuchsberger;Christian Fuchsberger;Jason A. Flannick;Jason A. Flannick;Tanya M. Teslovich;Anubha Mahajan

  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez

  • A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance.

    Alisa K. Manning;Alisa K. Manning;Alisa K. Manning;Robert A. Scott;Jonna L. Grimsby

  • Association between alcohol and cardiovascular disease:Mendelian randomisation analysis based on individual participant data

    Michael V Holmes;Michael V Holmes;Caroline E Dale;Luisa Zuccolo;Richard J Silverwood

  • Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

    Lars Lannfelt;Kaj Blennow;Henrik Zetterberg;Stellan Batsman

  • Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease'

    Peter Davies;Judith Resnick;Burton Resnick;Sid Gilman

  • The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway.

    Christian Haass;Cynthia A. Lemere;Anja Capell;Anja Capell;Martin Citron

  • An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans

    Robert A. Scott;Laura J. Scott;Reedik Mägi;Letizia Marullo

  • A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease

    Majid Nikpay;Anuj Goel;Hong-Hee Won;Leanne M. Hall

  • The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study

    Thomas W. Winkler;Anne E. Justice;Mariaelisa Graff;Llilda Barata

  • The genetic architecture of type 2 diabetes

    Christian Fuchsberger;Jason Flannick;Tanya M. Teslovich;Anubha Mahajan

Frequent Co-Authors

Martin Ingelsson
Martin Ingelsson Uppsala University
Andrew P. Morris
Andrew P. Morris University of Liverpool
Kaj Blennow
Kaj Blennow University of Gothenburg
Vilmantas Giedraitis
Vilmantas Giedraitis Uppsala University
Erik Ingelsson
Erik Ingelsson Stanford University
Cecilia M. Lindgren
Cecilia M. Lindgren University of Oxford
Bengt Winblad
Bengt Winblad Karolinska Institute
Henrik Zetterberg
Henrik Zetterberg University of Gothenburg
Matti Viitanen
Matti Viitanen University of Turku
Lars Lind
Lars Lind Uppsala University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine but want flexible options or prefer allied health professions, there are several online degrees to consider. The landscape of healthcare education is expanding, allowing students to start or advance their careers through online programs.

Pharmacy is a high-demand field, and a 3 year online pharmd provides a fast-tracked, convenient path to earning a doctorate. This format suits working professionals or those needing more flexibility.

For students interested in digital healthcare systems, pursuing a health information technology online degree offers strong job prospects in medical records, informatics, and data security roles.

If you’re looking to enter the healthcare workforce quickly, training through an online billing and coding course is affordable and practical. Find out the average cost of medical billing and coding program to plan your education budget and potential return on investment.

Nursing remains a top choice for career changers and lifelong caregivers. Explore the cheapest online nurse practitioner programs to advance your qualifications efficiently.

Whether you’re drawn to clinical roles or health technology, online programs make careers in medicine more accessible than ever.

Best Scientists Citing Lars Lannfelt

Trending Scientists

Recently Published Articles